Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Vaccines|June 27, 2025
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan IndividualsJonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesR Karl Malcolm, Ronald S Veazey, Leslie Geer, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 28, 2025
Nanoscale Biodegradable Printing for Designed Tuneability of Vaccine Delivery KineticsDavid J Peeler, Rujie Sun, Ceren Kütahya, et al.
NPJ Vaccines|July 4, 2025
Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung diseaseSophie L Higham, Ziyin Wang, Valarmathy Murugaiah, et al.
Journal of Virology|November 12, 2020
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1Katja Klein, Immaculate Nankya, Gabrielle Nickel, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
Frontiers in Immunology|December 12, 2022
Multi-component prime-boost <i>Chlamydia trachomatis</i> vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate modelEmma Lorenzen, Vanessa Contreras, Anja W Olsen, et al.
The Lancet. Infectious Diseases|August 17, 2019
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trialSonya Abraham, Helene B Juel, Peter Bang, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Vaccines|June 27, 2025
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan IndividualsJonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesR Karl Malcolm, Ronald S Veazey, Leslie Geer, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 28, 2025
Nanoscale Biodegradable Printing for Designed Tuneability of Vaccine Delivery KineticsDavid J Peeler, Rujie Sun, Ceren Kütahya, et al.
NPJ Vaccines|July 4, 2025
Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung diseaseSophie L Higham, Ziyin Wang, Valarmathy Murugaiah, et al.
Journal of Virology|November 12, 2020
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1Katja Klein, Immaculate Nankya, Gabrielle Nickel, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
Frontiers in Immunology|December 12, 2022
Multi-component prime-boost <i>Chlamydia trachomatis</i> vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate modelEmma Lorenzen, Vanessa Contreras, Anja W Olsen, et al.
The Lancet. Infectious Diseases|August 17, 2019
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trialSonya Abraham, Helene B Juel, Peter Bang, et al.
Pageof 21